Effects of nepicastat upon dopamine-β-hydroxylase activity and dopamine and norepinephrine levels in the rat left ventricle, kidney, and adrenal gland

References

• Boulpaep EL. Regulation of arterial pressure and cardiac output. In: Boron WF, Boulpaep EL, editors. Medical physiology: a cellular and molecular approach. Updated. 2nd.; 2012. 554–76 p, Saunders.
   Google Scholar
• Rosskopf D, Schürks M, Rimmbach C, Schäfers R. Genetics of arterial hypertension and hypotension. Naunyn-Schmiedeberg’s Archives of Pharmacol. 2007;374(5):429–69. doi:10.1007/s00210-007-0133-2.
   PubMed Web of Science ®Google Scholar
• Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116(6):1074–95. doi:10.1161/CIRCRESAHA.116.303603.
   PubMed Web of Science ®Google Scholar
• Grassi G, Bertoli S, Seravalle G. Sympathetic nervous system: role in hypertension and in chronic kidney disease. Curr Opin Nephrol Hypertens. 2012;21(1):46–51. doi:10.1097/MNH.0b013e32834db45d.
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013;113(6):739–53. doi:10.1161/CIRCRESAHA.113.300308.
   PubMed Web of Science ®Google Scholar
• Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta. 2010;1802(12):1259–67. doi:10.1016/j.bbadis.2010.02.004.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Stevenson LW. Beta-adrenergic blockers and survival in heart failure. N Engl J Med. 1996;334(21):1396–97. doi:10.1056/NEJM199605233342109.
   PubMed Web of Science ®Google Scholar
• Almeida L, Nunes T, Costa R, Rocha JF, Vaz-da-Silva M, Soares-da-Silva P. Etamicastat, a novel dopamine beta-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension. Clin Ther. 2013;35(12):1983–96. doi:10.1016/j.clinthera.2013.10.012.
   PubMed Web of Science ®Google Scholar
• Hegde SS, Friday KF. Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure. Curr Pharm Des. 1998;4(6):469–79.
   PubMed Web of Science ®Google Scholar
• Loureiro AI, Bonifacio MJ, Fernandes-Lopes C, Igreja B, Wright LC, Soares-da-Silva P. Etamicastat, a new dopamine-ss-hydroxylase inhibitor, pharmacodynamics and metabolism in rat. Eur J Pharmacol. 2014;740:285–94. doi:10.1016/j.ejphar.2014.07.027.
   PubMed Web of Science ®Google Scholar
• Soares-da-Silva P. Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol. 1986;333(3):219–23.
   PubMed Web of Science ®Google Scholar
• Soares-da-Silva P. A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery. Br J Pharmacol. 1987;90(1):91–98.
   PubMed Web of Science ®Google Scholar
• Igreja B, Pires NM, Bonifácio MJ, Loureiro AI, Fernandes-Lopes C, Wright LC, Soares-da-Silva P. Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat. Hypertens Res. 2015;38(1):30–38. doi:10.1038/hr.2014.143.
   PubMed Web of Science ®Google Scholar
• Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens. 2002;11(1):87–92.
   PubMed Web of Science ®Google Scholar
• Bonifácio MJ, Sousa F, Neves M, Palma N, Igreja B, Pires NM, Wright LC, Soares-da-Silva P. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.. Eur J Pharmacol. 2015;751:50–58. doi:10.1016/j.ejphar.2015.01.034.
   PubMed Web of Science ®Google Scholar
• Stanley WC, Lee K, Johnson LG, Whiting RL, Eglen RM, Hegde SS. Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor. J Cardiovasc Pharmacol, 1998;31(6):963–70.
   PubMed Web of Science ®Google Scholar
• Stanley WC, Li B, Bonhaus DW, Johnson LG, Lee K, Porter S, Walker K, Martinez G, Eglen RM, Whiting RL, et al. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol. 1997;121(8):1803–09. doi:10.1038/sj.bjp.0701315.
   PubMed Web of Science ®Google Scholar
• Pestana M, Soares-da-Silva P. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa. Br J Pharmacol. 1994;112(2):417–22.
   PubMed Web of Science ®Google Scholar
• Soares-da-Silva P, Fernandes MH. Inhibitory effects of guanosine 3ʹ:5ʹ-cyclic monophosphate on the synthesis of dopamine in the rat kidney. Br J Pharmacol. 1991;103(4):1923–27.
   PubMed Web of Science ®Google Scholar
• Soares-da-Silva P, Fernandes MH. Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat. Br J Pharmacol. 1992;105(4):811–16.
   PubMed Web of Science ®Google Scholar
• Nagatsu T, Udenfriend S. Photometric assay of dopamine- -hydroxylase activity in human blood. Clin Chem. 1972;18(9):980–83.
   PubMed Web of Science ®Google Scholar
• Kakimoto Y, Armstrong MD. On the identification of octopamine in mammals. J Biol Chem. 1962;237:422–27.
   PubMed Web of Science ®Google Scholar
• Kumar GK, Nanduri J, Peng YJ, Prabhakar NR. Neuromolecular mechanisms mediating the effects of chronic intermittent hypoxia on adrenal medulla. Respir Physiol Neurobiol. 2015;209:115–19. doi:10.1016/j.resp.2015.01.001.
   PubMed Web of Science ®Google Scholar
• Bondarenko NS, Murtazina AR, Nikishina YO, Sapronova AY, Ugrumov MV. Molecular mechanisms of synthesis of noradrenaline as an inducer of development in the adrenal glands of rats in ontogenesis. Dokl Biochem Biophys. 2017;472(1):23–26. doi:10.1134/S1607672917010070.
   PubMed Web of Science ®Google Scholar
• Kirpekar SM, Cervoni P, Couri D. Depletion and recovery of catecholamines and adenosine triphosphate of rat adrenal medulla after reserpine treatment. J Pharmacol Exp Therapeutics. 1963;142(1):71–75.
   PubMed Web of Science ®Google Scholar
• Meckler RL, Weaver LC. Splenic, renal, and cardiac nerves have unequal dependence upon tonic supraspinal inputs. Brain Res. 1985;338(1):123–35.
   PubMed Web of Science ®Google Scholar
• Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010;90(2):513–57. doi:10.1152/physrev.00007.2009.
   PubMed Web of Science ®Google Scholar
• Pires NM, Igreja B, Moura E, Wright LC, Serrão MP, Soares-da-Silva P. Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.. Hypertens Res. 2015;38(9):605–12. doi:10.1038/hr.2015.50.
   PubMed Web of Science ®Google Scholar
• Reid JL, Kopin IJ. Significance of plasma dopamine beta-hydroxylase activity as an index of sympathetic neuronal function. Proc Natl Acad Sci U S A. 1974;71(11):4392–94.
   PubMed Web of Science ®Google Scholar
• Arnaiz JM, Garcia AG, Horga JF, Kirpekar SM. Tissue and plasma catecholamines and dopamine beta-hydroxylase activity of various animal species after neurogenic sympathetic stimulation. J Physiol. 1978;285:515–29.
   PubMed Web of Science ®Google Scholar
• Iyer LM, Anantharaman V, Aravind L. The DOMON domains are involved in heme and sugar recognition. Bioinformatics. 2007;23(20):2660–64. doi:10.1093/bioinformatics/btm411.
   PubMed Web of Science ®Google Scholar
• Kruse LI, DeWolf WE Jr., Chambers PA, Goodhart PJ. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase. Biochemistry. 1986;25(23):7271–78.
   PubMed Web of Science ®Google Scholar
• Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci. 2000;57(8–9):1236–59.
   PubMed Web of Science ®Google Scholar
• Igreja B, Wright LC, Soares-da-Silva P. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine beta-hydroxylase inhibitor. J Am Soc Hypertens. 2016;10(3):207–16. doi:10.1016/j.jash.2015.12.011.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy KM. Arterial hypertension, angina pectoris, myocardial infarction and heart failure. In: Bennett PN, Brown MJ, Sharma P, editors. Clinical Pharmacology. 11th ed. Churchill Livingstone; 2012. p. 393–427.
   Google Scholar
• Lokhandwala MF, Hegde SS. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure. Am J Med. 1991;90(5B):2S–9S.
   PubMedGoogle Scholar
• Gomes P, Soares-da-Silva P. Dopamine. In: Baden M, editor. Cardiovascular hormone systems: from molecular mechanisms to novel therapeutics. Weinheim: Wiley-VCH; 2008. p. 251–93.
   Google Scholar